glutathione and multiple myeloma A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros Aiolos, to treat myeloma. Panel A shows the chemical structures Frontiers | Metabolic changes underlying
Frontiers Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Omega 3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation In Vitro Low Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants Glutathione: Lights and Shadows in Cancer Patients PMC Frontiers Multi omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





